Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model

• Emily A. Kendall ,

  * E-mail: ekendal2@jhmi.edu

  Affiliation Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, Maryland, United States of America

  http://orcid.org/0000-0002-0083-422X

  ⨯
• Sourya Shrestha,

  Affiliation Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, Maryland, United States of America

  http://orcid.org/0000-0002-6106-6834

  ⨯
• Ted Cohen,

  Affiliation Yale School of Public Health, Department of Epidemiology of Microbial Diseases, New Haven, Connecticut, United States of America

  ⨯
• Eric Nuermberger,

  Affiliation Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, Maryland, United States of America

  ⨯
• Kelly E. Dooley,

  Affiliations Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, Maryland, United States of America, Johns Hopkins University School of Medicine, Division of Clinical Pharmacology, Baltimore, Maryland, United States of America

  ⨯
• Lice Gonzalez-Angulo,

  Affiliation World Health Organization, Global TB Program, Geneva, Switzerland

  ⨯
• Gavin J. Churchyard,

  Affiliation Aurum Institute, Johannesburg, South Africa

  ⨯
• Payam Nahid,

  Affiliation University of California San Francisco, Division of Pulmonary and Critical Care Medicine, San Francisco, California, United States of America

  ⨯
• Michael L. Rich,

  Affiliations Partners In Health, Boston, Massachusetts, United States of America, Brigham and Women's Hospital, Division of Global Health Equity, Boston, Massachusetts, United States of America

  ⨯
• Cathy Bansbach,

  Affiliation Bill and Melinda Gates Foundation, Seattle, Washington, United States of America

  ⨯
• Thomas Forissier,

  Affiliation Bill and Melinda Gates Foundation, Seattle, Washington, United States of America

  ⨯
• Christian Lienhardt,

  Affiliation World Health Organization, Global TB Program, Geneva, Switzerland

  http://orcid.org/0000-0003-0233-893X

  ⨯
• David W. Dowdy

  Affiliation Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, Maryland, United States of America

  ⨯